Maulik Nanavaty - Jul 29, 2021 Form 3/A - Amendment Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Director
Signature
/s/ Josh Seidenfeld, Attorney-in-Fact for Maulik Nanavaty
Stock symbol
RANI
Transactions as of
Jul 29, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
8/2/2021, 07:44 PM
Date Of Original Report
Jul 29, 2021
Previous filing
Jun 2, 2021
Next filing
Aug 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RANI Class B Common Stock 52.8K Jul 29, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RANI Class A Common LLC Units Jul 29, 2021 Class A Common Stock 208K Direct F1, F2, F3
holding RANI Stock Option (Right to Buy) Jul 29, 2021 Class A Common Stock 79.2K $9.45 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correctly reflect the shares held.
F2 Represents Class A Common LLC Units of Rani Therapeutics, LLC, a direct subsidiary of the Issuer. The Class A Common LLC Units are redeemable at the election of the Reporting Person at any time for newly-issued Class A Common Stock of the Issuer ("Class A Shares") on a one-for-one basis or, if mutually agreed with the Issuer, a cash payment equal to the volume weighted average market price of one Class A Share for each Class A Common LLC Unit redeemed (subject to customary adjustments, including for stock splits, stock dividends and reclassifications). However, the Issuer may elect to effect a direct exchange of such Class A Shares (or such cash, if mutually agreed) for such Common LLC Units.
F3 Upon the redemption or exchange by the Reporting Person of any Class A Common LLC Units, a number of Class B Common Stock of the Issuer ("Class B Shares") held by the Reporting Person equal to the number of Common LLC Units that are redeemed or exchanged will be automatically cancelled by the Issuer for no consideration.
F4 The shares subject to the option vest as follows: 1/36th of the shares subject to the option vest monthly over three years from June 17, 2021.
F5 This amendment is being filed to correctly reflect the exercise price of the Stock Option.